Titlebook: Human Pharmaceuticals in the Environment; Current and Future P Bryan W. Brooks,Duane B. Huggett Book 2012 Springer Science+Business Media,

Longitude

自負(fù)的人

Lina Gunnarsson,Erik Kristiansson,D. G. Joakim Larsson

閑聊

Bryan W. Brooks,Duane B. HuggettExplores the issue of pharmaceuticals, and other contaminants, in freshwater and coastal ecosystems.First book on pharmaceuticals in the environment to cover such a wide range of topics.All of the boo

Palatial

figurine

Incumbent

Book 2012, unprecedented global trade and digital communications, energy security, natural resource scarcities, climatic changes and environmental quality, emerging diseases and public health, biodiversity and habitat modifications are routinely touted by the popular press as they canvas global political agendas and scholarly endeavors.

使閉塞

978-1-4939-0163-0Springer Science+Business Media, LLC 2012

Nonconformist

Human Pharmaceuticals in the Environment978-1-4614-3473-3Series ISSN 1868-1344 Series E-ISSN 1868-1352

intangibility

Environmental Comparative Pharmacology: Theory and Application,s, assist in the selection of appropriate test organisms and endpoints and identify limitations with species extrapolations. Without any attempt to be comprehensive, we also give some selected examples on both theoretically and empirically derived pharmacokinetics and pharmacodynamic data in nontarget species.

micronutrients

A Look Backwards at Environmental Risk Assessment: An Approach to Reconstructing Ecological Exposurr both humans and ecosystems. Exposure reconstruction is a concept that can guide this shift in research focus. Exposure reconstruction, as defined in this chapter, is the characterization of exposures, environmental concentrations, and/or sources from internal biological measurements that are used to inform environmental decision-making (Fig. 1).